tradingkey.logo

Metagenomi Inc

MGX
1.540USD
+0.130+9.22%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
57.82MMarktkapitalisierung
VerlustKGV TTM

Metagenomi Inc

1.540
+0.130+9.22%

mehr Informationen über Metagenomi Inc Unternehmen

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Metagenomi Inc Informationen

BörsenkürzelMGX
Name des UnternehmensMetagenomi Inc
IPO-datumFeb 09, 2024
CEOIrish (Jian)
Anzahl der mitarbeiter202
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 09
Addresse5959 Horton St
StadtEMERYVILLE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94608
Telefon15108714880
Websitehttps://metagenomi.co/
BörsenkürzelMGX
IPO-datumFeb 09, 2024
CEOIrish (Jian)

Führungskräfte von Metagenomi Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.36M
-3830.00%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
824.33K
+246898.00%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-5239.00%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.36M
-3830.00%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
824.33K
+246898.00%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-5239.00%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.29%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.38%
Bernales (Sebastian Ph.D.)
3.12%
Andere
71.36%
Aktionäre
Aktionäre
Anteil
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.29%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.38%
Bernales (Sebastian Ph.D.)
3.12%
Andere
71.36%
Aktionärstypen
Aktionäre
Anteil
Corporation
15.85%
Individual Investor
12.68%
Investment Advisor
7.31%
Hedge Fund
3.18%
Venture Capital
3.00%
Investment Advisor/Hedge Fund
1.77%
Research Firm
1.39%
Sovereign Wealth Fund
0.67%
Andere
54.14%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
166
6.70M
17.86%
-8.85M
2025Q3
156
7.24M
19.30%
-9.50M
2025Q2
159
20.26M
54.19%
-7.71M
2025Q1
157
20.44M
54.67%
-7.64M
2024Q4
143
21.51M
57.48%
-2.78M
2024Q3
116
23.74M
63.40%
-1.13M
2024Q2
94
26.05M
69.54%
+4.67M
2024Q1
65
26.68M
71.20%
+16.22M

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Bayer HealthCare LLC
4.05M
10.79%
--
--
Sep 30, 2024
Thomas (Brian C)
2.36M
6.29%
-3.83K
-0.16%
Dec 05, 2025
Humboldt Capital, LLC
1.90M
5.05%
--
--
Apr 14, 2025
The Vanguard Group, Inc.
1.24M
3.31%
-16.13K
-1.28%
Sep 30, 2025
Bernales (Sebastian Ph.D.)
1.17M
3.12%
--
--
Apr 14, 2025
Irish (Jian)
824.33K
2.2%
+246.90K
+42.76%
Dec 05, 2025
Sozo Ventures LLC
581.58K
1.55%
--
--
Sep 30, 2025
Catalio Capital Management, LP
528.99K
1.41%
--
--
Sep 30, 2025
Peapod Lane Capital LLC
513.82K
1.37%
+5.71K
+1.12%
Sep 30, 2025
Millennium Management LLC
310.69K
0.83%
-72.34K
-18.89%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
Anteil0.01%
Avantis US Small Cap Equity ETF
Anteil0%
iShares Russell 2000 Value ETF
Anteil0%
Proshares Ultra Russell 2000
Anteil0%
ProShares Hedge Replication ETF
Anteil0%
Global X Russell 2000 ETF
Anteil0%
Schwab U.S. Small-Cap ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%
ProShares UltraPro Russell2000
Anteil0%
iShares Russell 2000 Growth ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI